COMPOUND, RADIOPHARMACEUTICAL COMPOSITION, USE OF A HUMAN COMPOUND OR BODY, AND IMAGE GENERATION METHODS OF AN ANIMAL OR HUMAN BODY, AND MONITORING THE EFFECT OF THE TREATMENT OF AN ANIMAL OR HUMAN BODY WITH A DRUG.
The present invention relates to new radiolabelled peptide-based compounds and their use for diagnostic imaging using positron emission tomography (PET). Such compounds may thus be used for diagnosis or therapy of, for example, malignant diseases, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's sarcoma.